Katie Thoren, P.h.D., is clinical chemist who specializes in translating new technologies into the clinical laboratory. Dr. Thoren focuses on improving the measurement of proteins and antibodies through use of techniques such as mass spectrometry, surface plasmon resonance and microfluidic immunoassays. In particular, she is using novel mass spectrometry approaches for the detection of monoclonal immunoglobulins in serum and urine. Although these techniques have been traditionally limited to research settings, they offer improved sensitivity and specificity over current clinical diagnostic methods. Dr. Thoren's work focuses on understanding how to best translate these techniques into routine use. Through collaborations with clinicians and in vitro diagnostic manufacturers, her translational research aims to keep the clinical laboratory at the forefront of diagnostic testing so we can provide the best possible care for our patients. Dr. Thoren's training in protein biochemistry, mass spectrometry and clinical chemistry make me well suited for this role.
